Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Wanzhou Green Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of high-end generic medications and active pharmaceutical ingredients (APIs). Established in 2010 and headquartered in the Hainan Free Trade Port, the company operates modern facilities that comply with international GMP standards. Its therapeutic focus includes cardiovascular health, anti-infectives, and digestive system disorders, with a product portfolio featuring widely used treatments such as Amlodipine Besylate and Azithromycin. The company is notably committed to green manufacturing practices, utilizing environmentally friendly chemical processes to reduce waste and energy consumption. Wanzhou Green Pharmaceutical serves both the domestic Chinese market and international clients through its contract manufacturing and formulation development services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Wanzhou Green Pharmaceutical.